We are live on !
Find out more
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.81B
AUM Growth
+$209M
(+3.7%)
Cap. Flow
-$89.8M
Cap. Flow % of AUM
Cap. Flow %
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
25.73%
Holding
880
New
85
Increased
289
Reduced
288
Closed
113
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$39.4M |
| 2 |
SS&C Technologies
SSNC
|
+$35.4M |
| 3 |
Dentsply Sirona
XRAY
|
+$34.3M |
| 4 |
Charles Schwab
SCHW
|
+$16.5M |
| 5 |
Analog Devices
ADI
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tractor Supply
TSCO
|
+$51.9M |
| 2 |
Burlington
BURL
|
+$42.3M |
| 3 |
CELG
Celgene Corp
CELG
|
+$38.2M |
| 4 |
T-Mobile US
TMUS
|
+$30.8M |
| 5 |
Manhattan Associates
MANH
|
+$25.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.33% |
| 2 | Healthcare | 16.31% |
| 3 | Technology | 15.88% |
| 4 | Consumer Discretionary | 12.37% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.83T
| $231M | 3.97% |
4,765,080
-8,520
| -0.2% | -$406K |
2013 Q2
16 quarters
|
|
2
Meta Platforms (Facebook)
META
$1.8T
| $175M | 3.02% |
1,159,919
-7,130
| -0.6% | -$1.06M |
2013 Q2
16 quarters
|
|
3
Mastercard
MA
$540B
| $162M | 2.79% |
1,335,299
-12,934
| -1% | -$1.53M |
2013 Q2
16 quarters
|
|
4
Starbucks
SBUX
$112B
| $160M | 2.76% |
2,750,639
+63,041
| +2% | +$3.81M |
2013 Q2
16 quarters
|
|
5
JPMorgan Chase
JPM
$886B
| $153M | 2.64% |
1,677,445
+27,986
| +2% | +$2.41M |
2013 Q2
16 quarters
|
|
6
Apple
AAPL
$5T
| $146M | 2.52% |
4,068,068
-36,872
| -0.9% | -$1.36M |
2013 Q2
16 quarters
|
|
7
Microsoft
MSFT
$3.96T
| $131M | 2.25% |
1,894,381
-5,069
| -0.3% | -$348K |
2013 Q2
16 quarters
|
|
8
American Tower
AMT
$85.3B
| $118M | 2.03% |
889,037
-4,114
| -0.5% | -$527K |
2013 Q2
16 quarters
|
|
9
Align Technology
ALGN
$10.6B
| $111M | 1.92% |
740,699
-72,864
| -9% | -$9.9M |
2013 Q2
16 quarters
|
|
10
Alphabet (Google) Class A
GOOGL
$4.21T
| $107M | 1.84% |
2,292,740
-24,200
| -1% | -$1.13M |
2015 Q3
7 quarters
|
|
11
Gartner
IT
$13.1B
| $102M | 1.75% |
822,690
-2,480
| -0.3% | -$288K |
2013 Q2
16 quarters
|
|
12
Edwards Lifesciences
EW
$50.3B
| $91.2M | 1.57% |
2,314,608
+6,000
| +0.3% | +$219K |
2013 Q2
16 quarters
|
|
|
CONE
13
DELISTED
CyrusOne Inc Common Stock
CONE
| $89.5M | 1.54% |
1,605,126
-1,035
| -0.1% | -$57.2K |
2015 Q1
9 quarters
|
|
14
Elevance Health
ELV
$93.3B
| $86.5M | 1.49% |
459,777
+16,581
| +4% | +$2.98M |
2013 Q3
15 quarters
|
|
15
Sherwin-Williams
SHW
$80.5B
| $86.1M | 1.48% |
736,383
+97,269
| +15% | +$10.9M |
2014 Q4
10 quarters
|
|
16
MarketAxess Holdings
MKTX
$5.79B
| $85.1M | 1.47% |
423,248
+21,487
| +5% | +$4.12M |
2013 Q2
16 quarters
|
|
17
Comcast
CMCSA
$77.7B
| $84.5M | 1.46% |
2,171,968
-5,756
| -0.3% | -$227K |
2013 Q2
16 quarters
|
|
|
CELG
18
DELISTED
Celgene Corp
CELG
| $82.8M | 1.43% |
637,735
-312,110
| -33% | -$38.2M |
2013 Q2
16 quarters
|
|
19
Microchip Technology
MCHP
$40.4B
| $77.9M | 1.34% |
2,018,192
-15,556
| -0.8% | -$612K |
2013 Q2
16 quarters
|
|
20
Merck
MRK
$354B
| $77.4M | 1.33% |
1,265,531
-6,308
| -0.5% | -$384K |
2013 Q2
16 quarters
|
|
21
Tyler Technologies
TYL
$14.7B
| $76M | 1.31% |
432,605
+10,965
| +3% | +$1.82M |
2013 Q2
16 quarters
|
|
22
Becton Dickinson
BDX
$52B
| $75.9M | 1.31% |
398,966
-3,635
| -0.9% | -$664K |
2013 Q2
16 quarters
|
|
23
Adobe
ADBE
$96.2B
| $75.6M | 1.3% |
534,393
+10,440
| +2% | +$1.43M |
2015 Q4
6 quarters
|
|
24
S&P Global
SPGI
$126B
| $74.5M | 1.28% |
510,608
-2,188
| -0.4% | -$304K |
2016 Q2
4 quarters
|
|
25
Home Depot
HD
$309B
| $70.3M | 1.21% |
458,007
-1,813
| -0.4% | -$278K |
2013 Q2
16 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
Geneva Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Geneva Advisors held 880 positions worth $5.81B, up 3.7% from $5.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geneva Advisors's Q2 2017 filing shows 85 new, 289 increased, 288 reduced and 113 closed positions. Its largest new stake was Golub Capital BDC: 98,783 shares worth $1.85M. The largest sale was Tractor Supply, an estimated $51.9M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
- Geneva Advisors's largest Q2 2017 buy was Golub Capital BDC: 98,783 shares worth $1.85M.
- Geneva Advisors added most to CME Group in Q2 2017, an estimated $39.4M increase.
- Geneva Advisors's biggest Q2 2017 reduction was Tractor Supply, cutting an estimated $51.9M.
- Geneva Advisors fully exited Syneos Health, Inc. Class A Common Stock in Q2 2017, selling an estimated $11.3M.
- Geneva Advisors's ten largest holdings make up 26% of its $5.81B portfolio in Q2 2017.
- Geneva Advisors opened 85 new positions and closed 113 in Q2 2017.
- Geneva Advisors's portfolio value rose 3.7% quarter-over-quarter to $5.81B.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.